November 2020, Volume 26, (Suppl 1) | Pharmaceutical Sciences

Search

ISSN: 1735-403X eISSN: 2383-2886

Submit Your Paper Editorial Board Instructions for Authors Instructions for Reviewers Contact Us Editorial Policies Peer Review Archive

Follower of ICMJE

Powered by:

November 2020, Volume 26, (Suppl 1)

Pharmaceutical Sciences is a peer-reviewed, and quarterly journal providing a forum for basic to clinical issues related to all areas of pharmaceutical sciences. It is the official journal of Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.
- Platinum Open Access (no processing or publication fees)
- Indexed in Web of Science Core Collection (Impact Factor 2023= 1.4) and Scopus (CiteScore 2023= 2.6)
- Average time to first decision in 2024 (all decisions): 15 days
- Time to first post-review decision in 2024: 2-10 weeks
- Acceptance rate in 2024: 10%
- Publications from 21 countries in 2024

Editorial COVID-19

Higher Education System in Light of Covid-19

Jalal Hanaee* , Mohammad Reza Rashidi

Pharm Sci. 2020;26(Suppl 1): S1-S2. doi: 10.34172/PS.2020.45

Scopus ID: 85097264895

Article

PDF

XML

Cited By:

1

1

Review COVID-19

COVID-19: A Devastating Pandemic

Punet Kumar* , Md Iftekhar Ahmad , Sangam Singh

Pharm Sci. 2020;26(Suppl 1): S3-S11. doi: 10.34172/PS.2020.34

Scopus ID: 85097274657

Article

PDF

XML

Cited By:

3

4

Review COVID-19

COVID-19: Clinical Characteristics and Molecular Levels of Candidate Compounds of Prospective Herbal and Modern Drugs in Indonesia

Robert Tungadi* , Teti Sutriyati Tuloli, Widysusanti Abdulkadir, Nurain Thomas, Madania Madania, Ani Mustapa Hasan, Zulfiayu Sapiun

Pharm Sci. 2020;26(Suppl 1): S12-S23. doi: 10.34172/PS.2020.50

Scopus ID: 85097264531

Article

PDF

XML

Cited By:

5

3

Review COVID-19

A Summary of Coronavirus Disease 2019: What We Should Know?

Ysrafil Ysrafil , Indwiani Astuti* , Rosdiana Mus, Noviyanty Indjar Gama, Dwi Rahmaisyah, Riskah Nur’amalia

Pharm Sci. 2020;26(Suppl 1): S24-S35. doi: 10.34172/PS.2020.82

Scopus ID: 85097275654

Article

PDF

XML

Cited By:

4

0

Review COVID-19

Investigational Drugs for the COVID 19 Pandemic – A Concise Review

Reena Sherin Parveen , Sherya Hegde, Veena Nayak*

Pharm Sci. 2020;26(Suppl 1): S36-S48. doi: 10.34172/PS.2020.80

Scopus ID: 85097283168

Article

PDF

XML

Cited By:

1

0

Mini Review

NSAIDs and COVID-19: A New Challenging Area

Hananeh Baradaran , Hadi Hamishehkar, Haleh Rezaee*

Pharm Sci. 2020;26(Suppl 1): S49-S51. doi: 10.34172/PS.2020.41

Scopus ID: 85097290006

Article

PDF

XML

Cited By:

5

5

Research Article COVID-19

In Silico Drug Repurposing of Penicillins to Target Main Protease M^proof SARS-CoV-2

Baby Krishnaprasad , Swastika Maity , Chetan Mehta , Akhil Suresh , Usha Y Nayak , Yogendra Nayak*

Pharm Sci. 2020;26(Suppl 1): S52-S62. doi: 10.34172/PS.2020.44

Scopus ID: 85097296158

Article

PDF

XML

Cited By:

3

3

Research Article COVID-19

Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors

Mohammad Rizki Fadhil Pratama , Hadi Poerwono , Siswandono Siswodihardjo*

Pharm Sci. 2020;26(Suppl 1): S63-S77. doi: 10.34172/PS.2020.57

Scopus ID: 85097303712

Article

PDF

XML

Cited By:

5

2

Commentary COVID-19

Prophylactic Use of Chloroquine May Impair Innate Immune System Response against SARS-Cov-2

Hamid Soraya*

Pharm Sci. 2020;26(Suppl 1): S78-S79. doi: 10.34172/PS.2020.29

Scopus ID: 85086764367

Article

PDF

XML

Cited By:

2

1

Commentary COVID-19

Dexmedetomidine: An All Sedation-in–One Drug in Critically Ill Patients with COVID-19

Ata Mahmoodpoor, Elyad Ekrami, Hassan Soleimanpour*

Pharm Sci. 2020;26(Suppl 1): S80-S81. doi: 10.34172/PS.2020.53

Scopus ID: 85097267928

Article

PDF

XML

Cited By:

5

2

Commentary COVID-19

Plasmapheresis: A New Strategy in the Treatment of COVID-19

Punet Kumar* , Md Iftekhar Ahmad , Sangam Singh

Pharm Sci. 2020;26(Suppl 1): S82-S83. doi: 10.34172/PS.2020.55

Scopus ID: 85097299809

Article

PDF

XML

Cited By:

1

0

Commentary COVID-19

Persistence of SARS-Cov-2 on the Beauty Products, Their Containers’ Surfaces, and the Possibility of Secondary and Cross-Contamination

Zahra Jannatdoust, Sara Shamekhi, Jalal Hanaee, Somaieh Soltani* , Alireza Garjani*

Pharm Sci. 2020;26(Suppl 1): S84-S86. doi: 10.34172/PS.2020.68

Scopus ID: 85097293410

Article

PDF

XML

Cited By:

2

2

Commentary COVID-19

Diabetes and the COVID-19 Pandemic: What Should the Diabetes Patients Know?

Moyad Shahwan* , Nageeb Hassan, Sahab Alkhoujah, Ammar Jairoun , Samer Zyoud, Sudhir Varma

Pharm Sci. 2020;26(Suppl 1): S87-S90. doi: 10.34172/PS.2020.75

Scopus ID: 85097277524

Article

PDF

XML

Cited By:

1

0

Commentary COVID-19

A Rapid Strategy for Repurposing Drugs for COVID-19

Maryam Khoubnasabjafari , Masoud Amanlou, Ahmadreza Dehpour, Abolghasem Jouyban*

Pharm Sci. 2020;26(Suppl 1): S91-S93. doi: 10.34172/PS.2020.76

Scopus ID: 85097265192

Article

PDF

XML

Cited By:

1

0

Indexing & Abstracting:

Follow us on LinkedIn
Follow us on Twitter